EUVIMEDEUVIMED entdecken
Crossref

Self-Assembled Molecular Glue Prodrug System for Enhanced Synergistic Tumor Therapy by Combining CDK12 Protein Degradation and Immunotherapy

Nan Zhang, Ruihao Li, Huaxing Shen, Huang Li, Siyao Liu, Hongli Liao, Wei Cong, Xiaochun Hu iD, Honggang Hu iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c02939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Nan Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Shanghai Integration and Innovation Center of Marine Medical Engineering, Shanghai Engineering Research Center of Organ Repair, S…. Hauptthemen laut MEDLINE: Prodrugs, Immunotherapy, Cyclin-Dependent Kinases, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Central Guidance on Local Science and Technology Development Fund of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsImmunotherapyCyclin-Dependent KinasesAntineoplastic AgentsTriple Negative Breast NeoplasmsAnimalsMiceFemaleCell Line, TumorHumansMice, Inbred BALB CNanoparticlesProteolysisTumor MicroenvironmentHydrogen Peroxide

Stichwörter der Autor:innen

H2O2-responsive molecular gluechemotherapyenhanced synergistic tumor therapyimmune checkpoint inhibitorprodrug strategy

Substanzen

ProdrugsCyclin-Dependent KinasesAntineoplastic AgentsHydrogen Peroxide

Autor:innen und Institutionen

  • School of Medicine, Shanghai Integration and Innovation Center of Marine Medical Engineering, Shanghai Engineering Research Center of Organ Repair, Shanghai University, Shanghai 200444, China.
  • Mini-Invasive Interventional Therapy Center, Shanghai East Hospital, Tongji University, Shanghai 200120, China.
  • School of Pharmacy, Chengdu Medical College, Chengdu 610083, China.

ORCID-Profile: Xiaochun Hu, Honggang Hu

Förderung

  • National Natural Science Foundation of China
  • Central Guidance on Local Science and Technology Development Fund of Sichuan Province

Zitieren

APA

Zhang, N., Li, R., Shen, H., Li, H., Liu, S., Liao, H., Cong, W., Hu, X., & Hu, H. (2025). Self-Assembled Molecular Glue Prodrug System for Enhanced Synergistic Tumor Therapy by Combining CDK12 Protein Degradation and Immunotherapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c02939

Vancouver

Zhang N, Li R, Shen H, Li H, Liu S, Liao H, et al. Self-Assembled Molecular Glue Prodrug System for Enhanced Synergistic Tumor Therapy by Combining CDK12 Protein Degradation and Immunotherapy. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c02939

BibTeX
@article{Zhang2025,
  author = {Zhang, Nan and Li, Ruihao and Shen, Huaxing and Li, Huang and Liu, Siyao and Liao, Hongli and Cong, Wei and Hu, Xiaochun and Hu, Honggang},
  title = {Self-Assembled Molecular Glue Prodrug System for Enhanced Synergistic Tumor Therapy by Combining CDK12 Protein Degradation and Immunotherapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c02939}
}
Kostenlos starten →